Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Catalent Revenue 2012-2019 | CTLT

Catalent annual/quarterly revenue history and growth rate from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Catalent revenue for the quarter ending March 31, 2019 was $0.618B, a 1.66% decline year-over-year.
  • Catalent revenue for the twelve months ending March 31, 2019 was $2.478B, a 3.45% increase year-over-year.
  • Catalent annual revenue for 2018 was $2.463B, a 18.7% increase from 2017.
  • Catalent annual revenue for 2017 was $2.075B, a 12.3% increase from 2016.
  • Catalent annual revenue for 2016 was $1.848B, a 0.94% increase from 2015.
  
Catalent Annual Revenue
(Millions of US $)
2018 $2,463
2017 $2,075
2016 $1,848
2015 $1,831
2014 $1,828
2013 $1,800
2012 $1,695
2011 $1,532
Catalent Quarterly Revenue
(Millions of US $)
Q3 2019 $618
Q2 2018 $623
Q1 2018 $552
Q4 2018 $685
Q3 2018 $628
Q2 2017 $606
Q1 2017 $544
Q4 2017 $617
Q3 2017 $533
Q2 2016 $484
Q1 2016 $442
Q4 2016 $532
Q3 2016 $438
Q2 2015 $455
Q1 2015 $423
Q4 2015 $510
Q3 2015 $447
Q2 2014 $456
Q1 2014 $418
Q4 2014 $520
Q3 2014 $453
Q2 2013 $441
Q1 2013 $414
Q4 2013
Q3 2013
Q4 2012
Q4 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.049B $2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.478B 37.25
Astellas Pharma (ALPMY) Japan $26.786B 13.13
Takeda Pharmaceutical (TAK) Japan $25.935B 8.10
Grifols, S.A (GRFS) Spain $15.044B 19.19
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.613B 25.12
Merck (MKGAF) Germany $13.590B 18.55
Ionis Pharmaceuticals (IONS) United States $9.533B 20.56
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.905B 0.00
Sage Therapeutics (SAGE) United States $8.736B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.407B 9.75
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.101B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.969B 17.86
FibroGen (FGEN) United States $3.783B 94.63
United Therapeutics (UTHR) United States $3.633B 0.00
Evotec AG (EVTCY) Germany $3.240B 44.36
Taro Pharmaceutical Industries (TARO) Israel $3.101B 11.11
Arrowhead Pharmaceuticals (ARWR) United States $3.045B 69.83
Nektar Therapeutics (NKTR) United States $2.976B 0.00
Tilray (TLRY) Canada $2.833B 0.00
PTC Therapeutics (PTCT) United States $2.663B 0.00
Xencor (XNCR) United States $2.196B 47.89
Zogenix (ZGNX) United States $2.189B 0.00
Portola Pharmaceuticals (PTLA) United States $1.968B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.49
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.477B 14.81
Corcept Therapeutics (CORT) United States $1.451B 19.94
Heron Therapeutics (HRTX) United States $1.443B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.392B 22.97
Ironwood Pharmaceuticals (IRWD) United States $1.387B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.200B 0.00
ArQule (ARQL) United States $1.147B 0.00
Aerie Pharmaceuticals (AERI) United States $1.101B 0.00
Radius Health (RDUS) United States $1.101B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.916B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.802B 3.57
TherapeuticsMD (TXMD) United States $0.675B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.640B 0.00
Endo (ENDP) Ireland $0.636B 1.12
Karyopharm Therapeutics (KPTI) United States $0.567B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.538B 0.00
Indivior (INVVY) United States $0.537B 1.94
Akebia Therapeutics (AKBA) United States $0.506B 0.00
Dermira (DERM) United States $0.488B 0.00
Concordia (CXRXF) Canada $0.476B 0.00
Aptorum Group (APM) China $0.469B 0.00
Dova Pharmaceuticals (DOVA) United States $0.436B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.429B 0.00
Translate Bio (TBIO) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.426B 0.00
Flexion Therapeutics (FLXN) United States $0.423B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.422B 19.20
Siga Technologies (SIGA) United States $0.409B 0.96
ChemoCentryx (CCXI) United States $0.403B 0.00
Collegium Pharmaceutical (COLL) United States $0.395B 0.00
ImmunoGen (IMGN) United States $0.388B 0.00
CV Sciences (CVSI) United States $0.378B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.325B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.318B 0.00
Xeris Pharmaceuticals (XERS) United States $0.309B 0.00
DURECT (DRRX) United States $0.294B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.284B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.277B 0.00
KalVista Pharmaceuticals (KALV) United States $0.277B 0.00
Recro Pharma (REPH) United States $0.277B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
CannTrust Holdings (CTST) Canada $0.273B 0.00
Lannett Co Inc (LCI) United States $0.270B 2.62
OptiNose (OPTN) United States $0.262B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.239B 0.00
Concert Pharmaceuticals (CNCE) United States $0.238B 0.00
Ardelyx (ARDX) United States $0.226B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
Calithera Biosciences (CALA) United States $0.207B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.197B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.179B 0.00
Molecular Templates (MTEM) United States $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.19
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.159B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.142B 0.00
Generex Biotechnology (GNBT) United States $0.136B 0.00
Majesco Entertainment (PTE) United States $0.127B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.117B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.109B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
Neos Therapeutics (NEOS) United States $0.095B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.086B 0.00
MediWound (MDWD) Israel $0.085B 0.00
Genocea Biosciences (GNCA) United States $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.59
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Natural Alternatives (NAII) United States $0.075B 7.48
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Otonomy (OTIC) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 591.00
Lipocine (LPCN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.065B 0.00
Novan (NOVN) United States $0.064B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Medicure (MCUJF) Canada $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Aclaris Therapeutics (ACRS) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Melinta Therapeutics (MLNT) United States $0.035B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
IsoRay (ISR) United States $0.026B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.41
Achieve Life Sciences (ACHV) United States $0.016B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Flex Pharma (SLRX) United States $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00